FDA Oks HIV drug from Glaxo-Pfizer joint venture

Federal regulators have approved a new HIV treatment from ViiV Healthcare, a joint venture between pharmaceutical giants GlaxoSmithKline PLC and Pfizer Inc. The Food and Drug Administration approved 50-milligram tablets of the drug Tivicay to be combined with other medications for the treatment of HIV-1 in adults and some children, the company said ... (more)

http://www.biosciencetechnology.com/news/2013/08/fda-oks-hiv-drug-glaxo-pfizer-joint-venture